Validated HILIC-MS/MS assay for determination of vindesine in human plasma: Application to a population pharmacokinetic study

Journal of Pharmaceutical and Biomedical Analysis

Volumn 96, Issue , 2014, Pages 31-36

  Zhu, Rong Hua ^a   Li, Huan De ^a   Cai, Hua Lin ^a   Jiang, Zhi Ping ^b   Xu, Ping ^a   Dai, Li Bo ^a   Peng, Wen Xing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

HILIC; MS MS; Pharmacokinetics; Vindesine; Vinorelbine

Indexed keywords

AMMONIUM ACETATE; FORMIC ACID; NAVELBINE; UNCLASSIFIED DRUG; VINDESINE; VINDESINE SULFATE; XI AI KE VIAL; ANTINEOPLASTIC AGENT; VINBLASTINE;

ADULT; ARTICLE; CHROMATOGRAPH; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN TISSUE; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LIMIT OF QUANTITATION; MALE; MASS SPECTROMETER; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATION STUDY; ANALOGS AND DERIVATIVES; CALIBRATION; CHEMISTRY; CLINICAL TRIAL; HEMATOLOGIC NEOPLASMS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; STANDARD; YOUNG ADULT;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; LIMIT OF DETECTION; MALE; MIDDLE AGED; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; VINBLASTINE; VINDESINE; YOUNG ADULT;

EID: 84897949779     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.03.017     Document Type: Article

References (19)

1. Bayssas M., Gouveia J., de Vassal F., Misset J.L., Schwarzenberg L., Ribaud P., Musset M., Jasmin C., Hayat M., Mathé G. Vindesine: a new vinca alkaloid. Recent Results Cancer Res. 1980, 74:91-97.
2. Dancey J., Steward W.P. The role of vindesine in oncology-recommendations after 10 years' experience. Anticancer Drugs 1995, 6:625-636.
3. Cvitkovic E., Wasserman E. Role of vindesine as neoadjuvant chemotherapy for non-small cell lung and head and neck cancers. Anticancer Drugs 1997, 8:734-745.
4. Sethi V.S., Burton S.S., Jackson D.V. A sensitive radioimmunoassay for vincristine and vinblastine. Cancer Chemother. Pharmacol. 1980, 4:183-187.
5. 125I-radiolabelled probe for vinblastine and vindesine radioimmunoassays: applications to measurements of vindesine plasma levels in man after intravenous injections and long-term infusions. Clin. Chim. Acta 1983, 129:57-69.
6. Nakano Y., Saita T., Fujito H. Development of a specific and sensitive enzyme-linked immunosorbent assay for vindesine. Yakugaku Zasshi 2012, 132:727-732.
7. Barthe L., Ribet J.P., Pélissou M., Degude M.J., Fahy J., Duflos A. Optimization of the separation of vinca alkaloids by nonaqueous capillary electrophoresis. J. Chromatogr. A 2002, 968:241-250.
8. Hussey R.L., Newlon W.M. High-performance liquid chromatographic and TLC determinations of desacetylvinblastine amide (vindesine) and its monosulfate salt. J. Pharm. Sci. 1978, 67:1319-1320.
9. Paci A., Mercier L., Bourget P. Identification and quantitation of antineoplastic compounds in chemotherapeutic infusion bags by use of HPTLC: application to the vinca-alkaloids. J. Pharm. Biomed. Anal. 2003, 30:1603-1610.
10. Beijnen J.H., Vendrig D.E., Underberg W.J. Stability of vinca alkaloid anticancer drugs in three commonly used infusion fluids. J. Parenter. Sci. Technol. 1989, 43:84-87.
11. De Smet M., Van Belle S.J., Storme G.A., Massart D.L. High-performance liquid chromatographic determination of vinca-alkaloids in plasma and urine. J. Chromatogr. 1985, 345:309-321.
12. Vendrig D.E., Teeuwsen J., Holthuis J.J. Determination of vinca alkaloids in plasma and urine using ion-exchange chromatography on silica gel and fluorescence detection. J. Chromatogr. 1988, 434:145-155.
13. Vendrig D.E., Teeuwsen J., Holthuis J.J. Analysis of vinca alkaloids in plasma and urine using high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 1988, 424:83-94.
14. Maeda S., Miwa Y. Multicomponent high-performance liquid chromatography/tandem mass spectrometry analysis of ten chemotherapeutic drugs in wipe samples. J. Chromatogr. B 2013, 921-922:43-48.
15. Rahmani R., Zhou X.J., Placidi M., Martin M., Cano J.P. In vivo and in vitro pharmacokinetics and metabolism of vinca alkaloids in rat. I. Vindesine (4-deacetyl-vinblastine 3-carboxyamide). Eur. J. Drug Metab. Pharmacokinet. 1990, 15:49-55.
16. Nelson R.L. The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer. Med. Pediatr. Oncol. 1982, 10:115-127.
17. Ohnuma T., Norton L., Andrejczuk A., Holland J.F. Pharmacokinetics of vindesine given as an intravenous bolus and 24-hour infusion in humans. Cancer Res. 1985, 45:464-469.
18. Rahmani R., Samak R., Bore P., Cano J.P. Clinical pharmacokinetics of vinca alkaloids. Bull. Cancer 1988, 75:195-200.
19. Guidance for Industry Bioanalytical Method Validation from FDA 2001, US Department of Health and Human Services, Food and Drug Administration, CDER, Rockville, USA.